| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,590 | 16,048 | 15,553 | 14,284 | | Cost of Revenue | 5,237 | 5,334 | 5,466 | 5,458 | | | Gross Profit |
-
| 10,714 | 10,087 | 8,826 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,540 | 6,578 | 5,758 | 5,519 | | Non Recurring | 4,989 |
-
|
-
|
-
| | Others | 1,525 | 1,165 | 1,178 | 939 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,971 | 3,151 | 2,368 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,701) | 2,971 | 3,151 | 2,368 | | Interest Expense | 1,398 | 1,411 | 1,333 | 1,352 | | Income Before Tax | (4,099) | 1,560 | 1,818 | 1,016 | | Income Tax Expense | (1,484) | 449 | 552 | 303 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,615) | 1,111 | 1,266 | 713 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,615) | 1,111 | 1,266 | 713 | | Preferred Stock And Other Adjustments | (260) | (257) | (254) |
-
| | | Net Income Applicable To Common Shares | ($2,875) | $854 | $1,012 | $713 |
|
0.51% Nasdaq 
Income Statement
